If you need more lookups,
subscriptions start at $34 USD/month.
Devanshi Darji Location
Toronto, ON, CA
Devanshi Darji Work
R and D Manager, Drug Project Coordinator, Project and Portfolio Management, AstraZeneca Rare Disease @ (January 2026 - Present)
Clinical Study Administrator, AstraZeneca Rare Disease @ (November 2024 - January 2026)
Country Operations Management Intern, AstraZeneca Rare Disease @ (January 2024 - November 2024)
Clinical Systems and Informatics Analyst @ (May 2023 - May 2024)
Head Graduate Teaching Assistant @ (June 2023 - April 2024)
Undergraduate Teaching Assistant @ (August 2021 - May 2023)
Education Development Exec, Young Women in Medicine @ (July 2020 - June 2023)
Undergraduate Thesis Student @ (August 2022 - May 2023)
Archway Mentor @ (February 2022 - May 2023)
Research Assistant @ (September 2021 - May 2023)
Residence Ambassador @ (September 2019 - May 2020)
Devanshi Darji Education
McMaster University
Master of Biomedical Discovery and Commercialization
2023-2024
McMaster University
Bachelor of Health Science (BHSc) (Biomedical Discovery and Commercialization)
2019-2023
Castlebrooke Secondary School 2015-2019
Devanshi Darji Skills
Communication
Community Service
Critical Thinking
Healthcare
Passionate about work
Responsiveness
Tenacious Work Ethic
Volunteering
Devanshi Darji Summary
Devanshi Darji, based in Toronto, ON, CA, is currently a R and D Manager, Drug Project Coordinator, Project and Portfolio Management, AstraZeneca Rare Disease at Alexion Pharmaceuticals, Inc.. Devanshi Darji brings experience from previous roles at Alexion Pharmaceuticals, Inc., Trillium Health Partners and School of Interdisciplinary Science - McMaster University. Devanshi Darji holds a 2023 - 2024 Master of Biomedical Discovery and Commercialization @ McMaster University. With a robust skill set that includes Communication, Community Service, Critical Thinking, Healthcare, Passionate about work and more. Devanshi Darji has 2 emails on RocketReach.
Looking for a different Devanshi Darji?
Find contact details for 700 million professionals.